Explain this page
Arphra AIPlain-English read on Taysha Gene Therapies, Inc.’s valuation06-22today
- Taysha Gene Therapies, Inc. (TSHA) Discusses Longer-Term Clinical Data and Program Update for TSHA-102 in Rett Syndrome Transcript9h
- Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)17d
- Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update47d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $12.00 (+83.77%)
Candlestick · 1Y
Open in chart workstation →TSHA
6.42+37.77%H 7.03L 4.03MA50 5.20MA200 —Avg vol 2.6M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.71% | +10.68% | +18.94% | +48.41% | +11.43% | +18.73% | +162.25% | +812.65% | -74.22% | -72.86% | -72.86% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$6.66
1 sh
Bid
$6.19
4 sh
Ask
$6.80
400 sh
Spread
$0.610
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Technology+2.51%
- Consumer Cyclical+0.30%
- Healthcare+0.01%
- Utilities-0.07%
- Financial Services-0.24%
- Consumer Defensive-0.30%
- Energy-0.45%
- Industrials-0.48%
- Communication Services-0.55%
- Basic Materials-0.66%
- Real Estate-0.99%
Top industries (issuer's industry highlighted)
- Biotechnology+0.28%
- Oil & Gas Energy+8.53%
- Business Equipment & Supplies+5.82%
- Semiconductors+5.24%
- Electronic Gaming & Multimedia+5.23%
- Advertising Agencies-5.20%
- Medical - Equipment & Services+5.08%
- Financial - Mortgages+4.08%
- Computer Hardware-3.67%
- Staffing & Employment Services-3.62%
- Internet Content & Information+3.58%
- Coal-3.56%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Taysha Gene Therapies, Inc. (TSHA) Discusses Longer-Term Clinical Data and Program Update for TSHA-102 in Rett Syndrome Transcriptseekingalpha.com·Jun 22, 2026
- Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)globenewswire.com·Jun 05, 2026
- Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Updateglobenewswire.com·May 06, 2026
Peers
No peer list available for TSHA.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|